[1] |
闫文娟. 急性肾损伤的研究进展[J]. 临床与病理杂志, 2019, 39(7): 1571-1575. DOI: 10.3978/j.issn.2095-6959.2019.07.032.YAN WJ. Research progress of acute kidney injury[J]. Int J Pathol Clin Med, 2019, 39(7): 1571-1575. DOI: 10.3978/j.issn.2095-6959.2019.07.032.
|
[2] |
ZUK A, BONVENTRE JV. Acute kidney injury[J]. Annu Rev Med, 2016, 67: 293-307. DOI: 10.1146/annurev-med-050214-013407.
|
[3] |
SKARUPSKIENĖ I, ADUKAUSKIENĖ D, KUZMINSKIENĖ J, et al. Mortality prediction in patients with acute kidney injury requiring renal replacement therapy after cardiac surgery[J]. Medicina (Kaunas), 2017, 53(4): 217-223. DOI: 10.1016/j.medici.2017.06.003.
|
[4] |
赵宏磊, 孙立忠. 主动脉外科手术后并发急性肾损伤的研究进展[J]. 中国医药, 2017, 12(9): 1423-1426. DOI: 10.3760/cma.j.issn.1673-4777.2017.09.039.ZHAO HL, SUN LZ. Research progress of acute kidney injury after aortic surgery[J]. Chin Med, 2017, 12(9): 1423-1426. DOI: 10.3760/cma.j.issn.1673-4777.2017.09.039.
|
[5] |
王延庆, 韩玉珍, 张进, 等. 肝移植术后血清肌红蛋白水平对患者新发急性肾损伤的预测价值[J]. 实用医学杂志, 2021, 37(1): 46-50. DOI: 10.3969/j.issn.1006-5725.2021.01.010.WANG YQ, HAN YZ, ZHANG J, et al. The predictive value of serum myoglobin level with the occurrence of acute renal injury in liver transplantation patients[J]. J Pract Med, 2021, 37(1): 46-50. DOI: 10.3969/j.issn.1006-5725.2021.01.010.
|
[6] |
CAO Q, WANG R, WANG Y, et al. Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia/reperfusion injury[J]. Kidney Int, 2020, 97(1): 130-142. DOI: 10.1016/j.kint.2019.07.019.
|
[7] |
BONVENTRE JV, YANG L. Cellular pathophysiology of ischemic acute kidney injury[J]. J Clin Invest, 2011, 121(11): 4210-4221. DOI: 10.1172/JCI45161.
|
[8] |
ZHENG L, GAO W, HU C, et al. Immune cells in ischemic acute kidney injury[J]. Curr Protein Pept Sci, 2019, 20(8): 770-776. DOI: 10.2174/1389203720666190507102529.
|
[9] |
OUYANG W, O'GARRA A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation[J]. Immunity, 2019, 50(4): 871-891. DOI: 10.1016/j.immuni. 2019.03.020.
|
[10] |
WAN X, HUANG WJ, CHEN W, et al. IL-10 deficiency increases renal ischemia-reperfusion injury[J]. Nephron Exp Nephrol, 2014, 128(1/2): 37-45. DOI: 10.1159/ 000366130.
|
[11] |
GHOLAMPOUR F, ROOZBEH J, JANFESHAN S, et al. Remote ischemic per-conditioning protects against renal ischemia-reperfusion injury via suppressing gene expression of TLR4 and TNF-α in rat model[J]. Can J Physiol Pharmacol, 2019, 97(2): 112-119. DOI: 10.1139/cjpp-2018-0543.
|
[12] |
HOU L, CHEN G, FENG B, et al. Small interfering RNA targeting TNF-α gene significantly attenuates renal ischemia-reperfusion injury in mice[J]. Curr Med Sci, 2016, 36(5): 634-638. DOI: 10.1007/s11596-016-1638-z.
|
[13] |
HU H, ZOU C. Mesenchymal stem cells in renal ischemia-reperfusion injury: biological and therapeutic perspectives[J]. Curr Stem Cell Res Ther, 2017, 12(3): 183-187. DOI: 10.2174/1574888X11666161024143640.
|
[14] |
钱道海, 宋国栋, 张洲, 等. 骨髓间充质干细胞对重症急性胰腺炎胰腺组织修复的促进作用研究[J/CD]. 中华细胞与干细胞杂志(电子版), 2019, 9(6): 351-357. DOI: 10.3877/cma.j.issn.2095-1221.2019.06.006.QIAN DH, SONG GD, ZHANG Z, et al. Positive effect of bone marrow-derived mesenchymal stem cells on the repair of pancreatic tissue in severe acute pancreatitis[J/CD]. Chin J Cell Stem Cell (Electr Edit), 2019, 9(6): 351-357. DOI: 10.3877/cma.j.issn.2095-1221.2019.06.006.
|
[15] |
邢丽, 宋尔霖, 贾西贝, 等. 骨髓干细胞通过多种机制促进缺血再灌注小鼠肾脏修复[J]. 实用医学杂志, 2019, 35(7): 1073-1078. DOI: 10.3969/j.issn.1006-5725.2019.07.014.XING L, SONG EL, JIA XB, et al. Stem cells contribute to the regeneration of renal injury after ischemia-reperfusionth rough multiple mechanism[J]. J Pract Med, 2019, 35(7): 1073-1078. DOI: 10.3969/j.issn.1006-5725.2019.07.014.
|
[16] |
AHMADI A, RAD NK, EZZATIZADEH V, et al. Kidney regeneration: stem cells as a new trend[J]. Curr Stem Cell Res Ther, 2020, 15(3): 263-283. DOI: 10.2174/1574888X15666191218094513.
|
[17] |
TAMMARO A, KERS J, SCANTLEBERY AML, et al. Metabolic flexibility and innate immunity in renal ischemia reperfusion injury: the fine balance between adaptive repair and tissue degeneration[J]. Front Immunol, 2020, 11: 1346. DOI: 10.3389/fimmu.2020.01346.
|
[18] |
DE WAAL MALEFYT R, ABRAMS J, BENNETT B, et al. Interleukin 10 (IL-10) inhibits cytokine synthesisby human monocytes: an autoregulatory role of IL-10produced by monocytes[J]. J Exp Med, 1991, 174(5): 1209-1220. DOI: 10.1084/jem.174.5.1209.
|
[19] |
LI JH, TANG Y, LV J, et al. Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion[J]. J Cell Mol Med, 2019, 23(6): 3867-3877. DOI: 10.1111/jcmm.14234.
|
[20] |
SAKAI K, NOZAKI Y, MURAO Y, et al. Protective effect and mechanism of IL-10 on renal ischemia-reperfusion injury[J]. Lab Invest, 2019, 99(5): 671-683. DOI: 10.1038/s41374-018-0162-0.
|
[21] |
SHEN ZY, ZHANG J, SONG HL, et al. Bone-marrow mesenchymal stem cells reduce rat intestinal ischemia-reperfusion injury, ZO-1 downregulation and tight junction disruption via a TNF-α-regulated mechanism[J]. World J Gastroenterol, 2013, 19(23): 3583-3595. DOI: 10.3748/wjg.v19.i23.3583.
|
[22] |
YAN M, SHU S, GUO C, et al. Endoplasmic reticulum stress in ischemic and nephrotoxic acute kidney injury[J]. Ann Med, 2018, 50(5): 381-390. DOI: 10.1080/07853890.2018.1489142.
|
[23] |
TEXTOR SC, ABUMOAWAD A, SAAD A, et al. Stem cell therapy for microvascular injury associated with ischemic nephropathy[J]. Cells, 2021, 10(4): 765. DOI: 10.3390/cells10040765.
|
[24] |
CHANGIZI-ASHTIYANI S, HAFAZEH L, GHASEMI F, et al. The effect of adipose-derived mesenchymal stem cells on renal function and histopathology in a rat model of ischemia-reperfusion induced acute kidney injury[J]. Iran J Basic Med Sci, 2020, 23(8): 999-1006. DOI: 10.22038/ijbms.2020.40334.9601.
|
[25] |
ZHANG ZY, HOU YP, ZOU XY, et al. Oct-4 enhanced the therapeutic effects of mesenchymal stem cell-derived extracellular vesicles in acute kidney injury[J]. Kidney Blood Press Res, 2020, 45(1): 95-108. DOI: 10.1159/000504368.
|
[26] |
YANG Z, ZHANG XR, ZHAO Q, et al. Knockdown of TNF-α alleviates acute lung injury in rats with intestinal ischemia and reperfusion injury by upregulating IL-10 expression[J]. Int J Mol Med, 2018, 42(2): 926-934. DOI: 10.3892/ijmm.2018.3674.
|
[27] |
WANG Z, GUAN D, HUO J, et al. IL-10 enhances human natural killer cell effector functions via metabolic reprogramming regulated by mTORC1 signaling[J]. Front Immunol, 2021, 12: 619195. DOI: 10.3389/fimmu. 2021.619195.
|
[28] |
石炳毅, 陈文, 刘志佳. 调节性免疫细胞在异种移植免疫中的作用[J]. 器官移植, 2020, 11(3): 321-325. DOI: 10.3969/j.issn.1674-7445.2020.03.001.SHI BY, CHEN W, LIU ZJ. The function of regulatory immunological cell in xenotransplantation immunity[J]. Organ Transplant, 2020, 11(3): 321-325. DOI: 10.3969/j.issn.1674-7445.2020.03.001.
|
[29] |
JANG HR, RABB H. Immune cells in experimental acute kidney injury[J]. Nat Rev Nephrol, 2015, 11(2): 88-101. DOI: 10.1038/nrneph.2014.180.
|
[30] |
PERICO N, CASIRAGHI F, REMUZZI G. Clinical translation of mesenchymal stromal cell therapies in nephrology[J]. J Am Soc Nephrol, 2018, 29(2): 362-375. DOI: 10.1681/ASN.2017070781.
|
[31] |
TANG C, HAN H, LIU Z, et al. Activation of BNIP3-mediated mitophagy protects against renal ischemia-reperfusion injury[J]. Cell Death Dis, 2019, 10(9): 677. DOI: 10.1038/s41419-019-1899-0.
|
[32] |
WANG Y, ZHU J, LIU Z, et al. The PINK1/PARK2/optineurin pathway of mitophagy is activated for protection in septic acute kidney injury[J]. Redox Biol, 2021, 38: 101767. DOI: 10.1016/j.redox.2020.101767.
|
[33] |
CHEN ZD, HU BC, SHAO XP, et al. Ascorbate uptake enables tubular mitophagy to prevent septic AKI by PINK1-PARK2 axis[J]. Biochem Biophys Res Commun, 2021, 554: 158-165. DOI: 10.1016/j.bbrc.2021.03.103.
|
[34] |
IP WKE, HOSHI N, SHOUVAL DS, et al. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages[J]. Science, 2017, 356(6337): 513-519. DOI: 10.1126/science.aal3535.
|